文献速递脊柱关节炎

银屑病关节炎患者体成分及IL-12/IL-23抑制治疗期间的变化

Body Composition in Patients With Psoriatic Arthritis and Changes During Interleukin-12/Interleukin-23 Inhibition.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-06-29

本研究横断面比较30例PsA患者与60例健康对照的体成分,并随访30例活动性PsA患者接受UST治疗6个月。PsA患者总瘦体重和四肢瘦体重较低、总脂肪量较高,30%患者骨骼肌量低于低肌肉量切点;UST治疗6个月后总瘦体重略降,脂肪量有增加趋势但无统计学意义。

要点

  • PsA患者较健康对照总瘦体重和四肢瘦体重更低、总脂肪量更高。
  • 30%的PsA患者骨骼肌量低于低肌肉量切点,对照组无此现象。
  • UST治疗6个月后总瘦体重略降,脂肪量增加趋势不显著。

核心结论

  • PsA患者较健康对照脂肪量更高、瘦体重更低。
  • UST治疗6个月后总瘦体重略降,脂肪量有增加趋势但未达显著。

研究设计与样本

  • 基线横断面比较30例PsA患者与60例按年龄、性别、绝经状态和BMI匹配的无PsA健康对照。
  • 30例活动性PsA患者接受UST治疗并开放随访6个月,基线及治疗6个月测量体成分。

主要发现

  • PsA患者总瘦体重低于健康对照(P=0.013),四肢瘦体重亦较低(P=0.010)。
  • PsA患者总脂肪量高于健康对照(P<0.001)。
  • 30%的PsA患者骨骼肌量低于低肌肉量切点(男7.26 kg/m2,女5.5 kg/m2),对照组无此现象。
  • UST治疗6个月后18例PsA患者BMI无显著变化。
  • UST治疗6个月后总瘦体重略降(P=0.046),脂肪量有增加趋势但不显著,四肢瘦体重和骨骼肌质量指数无显著变化。

关键数值与推荐

  • 低肌肉量切点:男性7.26 kg/m2,女性5.5 kg/m2。
  • PsA患者总瘦体重与对照比较P=0.013,四肢瘦体重P=0.010,总脂肪量P<0.001。
  • UST治疗6个月后总瘦体重变化P=0.046。

临床怎么用

  • 评估PsA患者体成分时需关注脂肪量增加和瘦体重减少,即使BMI正常。
  • UST治疗期间应监测体成分变化,总瘦体重可能略降而脂肪量有增加趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about body composition in patients with psoriatic arthritis (PsA). Our objective was to compare body composition parameters in PsA patients and healthy controls and then investigate the effects of ustekinumab (UST) on body composition in patients with PsA. METHODS: At baseline, 30 PsA patients were compared cross-sectionally with 60 healthy controls without PsA, matched for age, sex, menopausal status, and body mass index (BMI). Thirty active PsA patients treated with UST were included in a 6-month open follow-up study. Body composition parameters were measured at baseline and 6 months of treatment. RESULTS: Body composition parameters were different in PsA patients compared to healthy controls; in PsA patients, total and appendicular lean mass were lower (P = 0.013 and P = 0.010, respectively), whereas total fat mass was higher (P < 0.001). In 30% of the PsA patients, skeletal muscle mass was below the cutoff for low muscle quantity (men 7.26 kg/m2 , women 5.5 kg/m2 ), whereas no such change was observed in the control group. After 6 months of treatment with UST, there was no significant change in BMI in 18 of the PsA patients. Total lean mass decreased slightly (P = 0.046), whereas fat mass tended to increase, but not significantly. No significant changes in appendicular lean mass and skeletal muscle mass index were observed. CONCLUSION: In this study, we found that PsA patients had higher fat mass and lower lean mass than healthy controls. At 6-months of treatment, total lean mass decreased slightly, whereas fat mass tended to increase, but not significantly.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Paccou J, Bavière W, Sornay-Rendu E, et al. Body Composition in Patients With Psoriatic Arthritis and Changes During Interleukin-12/Interleukin-23 Inhibition. Arthritis Care Res (Hoboken). 2022. PMID: 33973385. doi:10.1002/acr.24623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。